Is AMD or Broadcom the Best AI Chip Stock After Nvidia?

Broadcom is portrayed as the better AI chip stock versus AMD, with management reiterating a long-term target of $100 billion in annual AI chip sales starting in fiscal 2027. Broadcom generated $10.8 billion in AI revenue in Q2, while AMD's data center revenue rose 57% year over year to $5.8 billion in Q1 2026 and it announced a 6-gigawatt supply deal with Meta. The article favors Broadcom's custom silicon strategy and says its post-earnings pullback creates an attractive entry point.

Analysis

The market is likely underappreciating how the AI capex mix is changing. The next leg of spend is less about raw accelerator count and more about workload-specific optimization, which structurally favors custom silicon vendors over merchant GPU suppliers. That creates a second-order squeeze on the ecosystem: networking, memory bandwidth, and power-management vendors remain beneficiaries, but the economic rent migrates from the general-purpose compute layer toward design-in and deployment control.

AVGO’s edge is not just product differentiation; it is customer lock-in through co-development timelines that are long enough to outlast a single budget cycle. Once a hyperscaler commits engineering bandwidth to a custom roadmap, switching costs rise sharply because the replacement path is not a component swap but an architecture reset. That makes the revenue stream stickier than headline growth estimates imply, and it also means consensus likely still undervalues the durability of the earnings ramp into the 2027 window.

AMD’s issue is less about execution than about distribution. Even if product competitiveness improves, CUDA inertia and incumbent software tooling slow share gains in the exact workloads that matter most for strategic inference deployment. The contrarian angle is that AMD may still be a useful hedge against a Broadcom disappointment: if custom silicon adoption slips, capital rotates back to more liquid merchant GPU exposure, but the probability-weighted path still favors AVGO because inference economics should force buyers toward efficiency over brute-force performance.

The main risk to the bullish AVGO setup is timing, not thesis. If hyperscaler deployment schedules slip by even 1-2 quarters, the market will keep discounting the eventual revenue curve and punish near-term guidance. NVDA remains the cleanest barometer for whether the AI spend cycle is broadening or just being reallocated, while META and GOOGL are the most important downstream confirmation signals because they can validate custom silicon demand without needing external customer wins.

Key Decisions for Investors

• Long AVGO on post-earnings weakness with a 3-6 month horizon; use pullbacks to add because the setup is driven by 2027+ revenue visibility, not the next quarter. Risk/reward favors the long side as long as custom-silicon bookings continue to compound.
• Pair trade: long AVGO / short AMD over the next 1-3 quarters. This expresses the view that workload-specific design wins will convert to monetization faster than general-purpose GPU share gains; stop if AMD posts two consecutive upside revenue surprises tied to hyperscaler adoption.
• Use META and GOOGL as confirmation trades rather than core longs; add on evidence of custom chip deployment acceleration over the next 2 earnings cycles, since those platforms validate the inference migration thesis for AVGO.
• Fade NVDA on strength only tactically, not structurally. NVDA remains the ecosystem benchmark, but if inference economics keep shifting toward bespoke architectures, upside should compress relative to AVGO over 6-12 months.
• For options, consider AVGO call spreads 6-9 months out to monetize the valuation gap without paying full volatility; the thesis is that the market rerates slowly once the custom silicon revenue curve becomes more visible.